ZA937453B - 1-substituted oxindoles and azaoxindoles as novel cognition enhancers - Google Patents

1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Info

Publication number
ZA937453B
ZA937453B ZA937453A ZA937453A ZA937453B ZA 937453 B ZA937453 B ZA 937453B ZA 937453 A ZA937453 A ZA 937453A ZA 937453 A ZA937453 A ZA 937453A ZA 937453 B ZA937453 B ZA 937453B
Authority
ZA
South Africa
Prior art keywords
azaoxindoles
novel
cognition enhancers
substituted oxindoles
oxindoles
Prior art date
Application number
ZA937453A
Other languages
English (en)
Inventor
Christopher Allan Teleha
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA937453B publication Critical patent/ZA937453B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA937453A 1992-10-07 1993-10-07 1-substituted oxindoles and azaoxindoles as novel cognition enhancers ZA937453B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/957,152 US5296478A (en) 1992-10-07 1992-10-07 1-substituted oxindoles as cognition enhancers

Publications (1)

Publication Number Publication Date
ZA937453B true ZA937453B (en) 1995-04-07

Family

ID=25499153

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937453A ZA937453B (en) 1992-10-07 1993-10-07 1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Country Status (7)

Country Link
US (2) US5296478A (xx)
AU (1) AU5292893A (xx)
IL (1) IL107177A0 (xx)
MX (1) MX9306234A (xx)
TW (1) TW268943B (xx)
WO (1) WO1994007891A1 (xx)
ZA (1) ZA937453B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
PT813411E (pt) * 1995-02-15 2002-07-31 Takeda Chemical Industries Ltd Utilizacao de derivados de vinpocetina para inibicao da producao ou da secrecao de proteina amiloide beta
HRP980429A2 (en) 1997-08-14 1999-06-30 Jianguo Yin Crystalline 10,10-bis ((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same
US20050101929A1 (en) * 2002-01-17 2005-05-12 Andrew Waksmundzki Absorbent core with three-dimensional sub-layer
AR056968A1 (es) * 2005-04-11 2007-11-07 Xenon Pharmaceuticals Inc Compuestos espiro-oxindol y composiciones farmacéuticas
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
AR053713A1 (es) * 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
US20080176793A1 (en) * 2006-09-18 2008-07-24 The Regents Of The University Of California Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects
CL2007002953A1 (es) * 2006-10-12 2008-02-01 Xenon Pharmaceuticals Inc Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia.
TW200833695A (en) * 2006-10-12 2008-08-16 Xenon Pharmaceuticals Inc Use of spiro-oxindole compounds as therapeutic agents
CN101522685A (zh) * 2006-10-12 2009-09-02 泽农医药公司 三环螺-吲哚酮衍生物及其作为治疗剂的用途
US8101647B2 (en) * 2008-10-17 2012-01-24 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
RU2011119626A (ru) * 2008-10-17 2012-11-27 Ксенон Фармасьютикалз Инк. Спирооксиндольные соединения и их применение в качестве терапевтичеких средств
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
WO2011047173A2 (en) * 2009-10-14 2011-04-21 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
EP2488531B1 (en) * 2009-10-14 2014-03-26 Xenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
WO2011106729A2 (en) 2010-02-26 2011-09-01 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
WO2016127068A1 (en) 2015-02-05 2016-08-11 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
CN106565683B (zh) * 2016-09-30 2019-03-12 江汉大学 一种合成3-羟基氧化吲哚衍生物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314954A (en) * 1964-12-09 1967-04-18 Parke Davis & Co 1-(diloweralkylamino)-3-(aminoloweralkyl)-3-phenyloxindoles
US3595866A (en) * 1970-01-19 1971-07-27 Parke Davis & Co 1-amino-3-aminoalkyl-3-phenyloxindole-compounds
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
EP0419561A1 (en) * 1988-06-14 1991-04-03 Schering Corporation Heterobicyclic compounds having antiinflammatory activity
US5206261A (en) * 1989-07-25 1993-04-27 Taiho Pharmaceutical Company, Limited Oxindole derivative
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5278162A (en) * 1992-09-18 1994-01-11 The Du Pont Merck Pharmaceutical Company 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man

Also Published As

Publication number Publication date
AU5292893A (en) 1994-04-26
TW268943B (xx) 1996-01-21
US5428035A (en) 1995-06-27
WO1994007891A1 (en) 1994-04-14
IL107177A0 (en) 1994-01-25
US5296478A (en) 1994-03-22
MX9306234A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
ZA937453B (en) 1-substituted oxindoles and azaoxindoles as novel cognition enhancers
AU662997B2 (en) Condensed heterocyclic derivative and weedkiller
GB9204769D0 (en) Workcentre and supports
AU3217897A (en) Analogs of cc-1065 and the duocarmycins
ZA932582B (en) Indoles
EP0572162A3 (en) Sense fet and fast amplifier
HU9502440D0 (en) Indoles as insecticides and acaricides
GB9204770D0 (en) Workcentre and supports
AU2448292A (en) Pyrimidine derivative and weedkiller
AU3359493A (en) Determination of haptens
IL104472A0 (en) Substituted hexahydro-azepinones and tetrahydro-benzazepinones
EP0532288A3 (en) Composites and methods of making the same
AU108633S (en) Combined tuner and amplifier
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
AU4642793A (en) Grip enhancer
IL106811A0 (en) Substituted pyrroles
HU9500193D0 (en) Pyridoindolo-benzo-diazepines and derivatives as antipsychotics
GB2274507B (en) Handlamps and torches
IL105754A0 (en) Novel pyrrolidinones
AU8110191A (en) Novel spergualin-related compound and use thereof
AU5748994A (en) Potent and specific chemically-conjugated immunotoxins
GB9207843D0 (en) An amplifier
PL296873A1 (en) Substituted and heterocyclic phtalides
GB9207973D0 (en) Improvements relating to telecines and the like
GB9209249D0 (en) Motorcycle and sidecar combination